Herpes simplex viral-vector design for efficient transduction of nonneuronal cells without cytotoxicity

Y Miyagawa, P Marino, G Verlengia… - Proceedings of the …, 2015 - National Acad Sciences
Y Miyagawa, P Marino, G Verlengia, H Uchida, WF Goins, S Yokota, DA Geller, O Yoshida…
Proceedings of the national academy of sciences, 2015National Acad Sciences
The design of highly defective herpes simplex virus (HSV) vectors for transgene expression
in nonneuronal cells in the absence of toxic viral-gene activity has been elusive. Here, we
report that elements of the latency locus protect a nonviral promoter against silencing in
primary human cells in the absence of any viral-gene expression. We identified a CTCF
motif cluster 5′ to the latency promoter and a known long-term regulatory region as
important elements for vigorous transgene expression from a vector that is functionally …
The design of highly defective herpes simplex virus (HSV) vectors for transgene expression in nonneuronal cells in the absence of toxic viral-gene activity has been elusive. Here, we report that elements of the latency locus protect a nonviral promoter against silencing in primary human cells in the absence of any viral-gene expression. We identified a CTCF motif cluster 5′ to the latency promoter and a known long-term regulatory region as important elements for vigorous transgene expression from a vector that is functionally deleted for all five immediate-early genes and the 15-kb internal repeat region. We inserted a 16.5-kb expression cassette for full-length mouse dystrophin and report robust and durable expression in dystrophin-deficient muscle cells in vitro. Given the broad cell tropism of HSV, our design provides a nontoxic vector that can accommodate large transgene constructs for transduction of a wide variety of cells without vector integration, thereby filling an important void in the current arsenal of gene-therapy vectors.
National Acad Sciences